The effects of stroma-free and dextran-conjugated hemoglobin on hemodynamics and carotid blood flow in hemorrhaged guinea pigs

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 27, Issue 1, 1999, Pages 49-64

  Caron, A ^a   Menu, P ^a   Faivre Fiorina, B ^a   Labrude, P ^a   Vigneron, C ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODYNAMICS; HEMOGLOBIN; LIVING SYSTEMS STUDIES; NITROGEN OXIDES; POLYSACCHARIDES; RESUSCITATION;

DEXTRAN; MEAN ARTERIAL PRESSURE; VASCULAR RESISTANCE INDEX; VASODILATION;

BLOOD SUBSTITUTES;

ALBUMIN; BENZENE DERIVATIVE; DEXTRAN; DEXTRAN BENZENETETRACARBOXYLIC ACID; HEMOGLOBIN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLEEDING; CAROTID ARTERY FLOW; CONJUGATION; CONTROLLED STUDY; GUINEA PIG; HEART RATE; HEMODYNAMICS; HYPOVOLEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TRANSPORT; RESUSCITATION; SHEAR STRESS; VASCULAR RESISTANCE; VASODILATATION;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0033063388     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199909117483     Document Type: Article

References (31)

1. Kreimeier U, Messmer K: Blood flow distribution during shock. In: Winslow R, Vandegriff KD, Intaglietta M (eds): Blood substitutes. New challenges. Birkhäuser, pp.34-59 (1996).
2. Carson JL, Willet LR: Is a hemoglobin of 10 g/dL required for surgery ? Med Clin North Am. 77:335-347 (1993).
3. Dietz N, Joyner MJ, Warner M: Blood substitutes: Fluids, drugs, or miracle solutions ? Anesth Analg 82:390-405 (1996).
4. Viele MK, Weiskopf RB, Fischer D: Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 86:848-858 (1997).
5. Kim HW, Greenburg AG: Hemoglobin mediated vasoctivity in isolated vascular rings. Art Cells Blood Subs Immob Biotech 23:303-309 (1995).
6. Nakai K, Ohta T, Sakuma I, Akama K, Kobayashi Y, Tokuyama S, Kitabatake A, Nakazato Y, Takahashi TA, Sadayoshi S: Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: Comparison between acellular hemoglobin derivatives and cellular hemoglobins. J Cardiovasc Pharmacol 28:115-123 (1996).
7. Kosaka H, Uozomi M, Tyuma I: The interaction between nitrogen oxides and hemoglobin and endothelium-relaxing factor. Free Radic Biol Med 7:653-658 (1989).
8. Collins P, Burman J, Chung HI, Fox K: Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation 87:80-85 (1993).
9. Jia L, Bonaventura C, Bonaventura J, Stamler JS: S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380:221-226 (1996).
10. Ohlstein EH, Storer BL: Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77:274-278 (1992).
11. Gulati A, Singh G., Rebello S, Sharma AC: Effect of diaspirin crosslinked hemoglobin and stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentration in rats. Life Sci 56:1433-1442 (1995).
12. Gulati A, Sharma AC, Singh G: Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 24:137-147 (1996).
13. Prouchayret F, Fasan G, Grandgeorge M, Vigneron C, Menu P, Dellacherie E: A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterisation. In: Chang TMS (ed): Blood substitutes and oxygen carriers. Marcel Dekker, Inc.; pp 144-147 (1993).
14. Faivre B, Menu P, Labrude P, Grandgeorge M, Vigneron C, Dellacherie E: A potential blood substitute from carboxylic dextran and oxyhemoglobin. II. Physicochemical and physiological assessments. Preliminary results on guinea pig. In: Chang TMS (ed): Blood substitutes and oxygen carriers. Marcel Dekker, Inc.; pp 392-395 (1993).
15. Menu P, Faivre B, Labrude P, Riffard P, Grandgeorge M, Vigneron C: Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II. Pharmacotoxicological evaluation. Biomat Art Cells Immob Biotech 22:551-558 (1994).
16. Menu P, Labrude P, Grandgeorge M, Vigneron C: Importance of purification on transfusional efficacy of haemoglobin solution. Int J Artif Organs 14:672-675 (1991).
17. Hartley CJ, Cole JS: An ultrasonic pulsed Doppler system for measuring blood flow in small vessels. J Appl Physiol 37:626-629 (1974).
18. Haywood JR, Shaffer RA, Fastenow C, Fink GD, Brody MJ: Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol 241:H273-H278 (1981).
19. Leftheriotis G, Geraud JM, Preckel MP, Saumet JL: Cerebral blood flow and resistances during hypotensive haemorrhage in the rabbit: Transcranial Doppler and laser-Doppler flowmetry. Clin Physiol 15:537-545 (1995).
20. Little RA, Gorman D, Allgöwer M: The shock index revisited. In: Vincent JL. (ed): Update in intensive care and emergency medicine, vol 10. Springer, Berlin Heidelberg New York; pp 505-513 (1990).
21. Chang TMS, Varma R: Effect of a single replacement of one of ringer lactate, hypertonic saline/dextran, 7% albumin, stroma-free hemoglobin, oraffinose polyhemoglobin or whole blood on the long term survival of unanesthetized rats with lethal hemorrhagic shock after 67% acute blood loss. Biomat Art Cells Immob Biotech 20:503-510 (1992).
22. Thiemermann C, Szabo C, Mitchell JA, Vane JR: Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 90:267-271 (1993).
23. Kvetnansky R, Pacak K, Tokarev D, Jelokova J, Jezova D, Rusnak M. Chronic blockade of nitric oxide synthesis elevates plasma levels of catecholamines and their metabolites at rest and during stress in rats. Neurochem.Res. 22:995-1001 (1997).
24. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122:301-308 (1993).
25. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142 (1991).
26. Alayash AI, Cashon RE: Hemoglobin and free radicals: Implications for the development of a safe blood substitute. Mol Med Today 1:122-127 (1995).
27. Gulati A, Sen AP, Sharma AC, Singh G. Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat. Am.J.Physiol. H827-H836 (1997).
28. Biro GP, Taichmann GC, Lada B, Keon WJ, Rosen AL, Sehgal LR: Coronary vascular actions of stroma-free hemoglobin preparations. Art Organs 12:40-50 (1988).
29. Vogel WM, Dennis RC, Cassidy .G, Apstein CS, Valeri CR: Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 251:H413-H420 (1986).
30. Bunn HF, Esham WT, Bull RW: The renal handling of hemoglobin. I: Glomerular filtration. J Exp Med 129:909-922 (1969).
31. Menu P, Donner M, Faivre B, Labrude P, Vigneron C: In vitro effect of dextran-benzene-tetracarboxylate hemoglobin on human blood rheological properties. Art Cells Blood Subs Immob Biotech 23:319-330 (1995).